Cargando…
2244. Clinical Outcomes with Extended Infusion (EI) vs. Intermittent Infusion (II) of Cefepime (FEP), Piperacillin/Tazobactam (TZP), and Meropenem (MEM) in Patients with Gram-Negative (GN) Bacteremia
BACKGROUND: The increase in drug-resistant pathogens has prompted interest in dosing of β-lactams (BLs) via EI. Available data on this practice are conflicting, rarely assess non-critically ill patients or low MIC pathogens, and do not focus on outcomes other than clinical cure or mortality. Further...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810835/ http://dx.doi.org/10.1093/ofid/ofz360.1922 |